In vitro assays of angiogenesis typically study the behavior of endothelial cells within a controlled environment. Fundamentally, these in vitro studies are based on purified endothelial cell cultures or carefully controlled co-culture with another cell type (i.e., fibroblasts, immune cells, pericytes, tumor cells).

The global Angiogenesis Assay Kit market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Angiogenesis Assay Kit volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Angiogenesis Assay Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Angiogenesis Assay Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Angiogenesis Activation Assay Kit
Angiogenesis Inhibition Assay Kit

Segment by Application
Academic Institution
Biotech Companies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Thermo Fisher Scientific
Abcam
PromoCell GmbH
Merck KGaA
Trevigen
Kollodis BioSciences